News

Scientific breakthroughs take center stage at the International AIDS Society Conference as global HIV funding and political support erode.
Receiving treatment within the first month of life could protect children for at least three years, a study suggests.
Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...
To find out what may be behind these numbers, Dr. Ann Khalsa, a clinician at the Valleywise Health McDowell Clinic spoke with ...
In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...
The Midwest AIDS Training and Education Center’s funding will be cut completely in the current budget proposal for fiscal ...
HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...
Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.
In a recent landmark study, scientists have unveiled how HIV-1 penetrates the cell's nuclear barrier—a discovery that could reshape antiviral strategies. The research, led by Professor Peijun Zhang, ...
Research students at McDaniel College are spending part of their summer on a multiyear project that could one day keep viruses like COVID-19 from spreading.
In a letter, the Long Beach Democrat asked Health and Human Services Secretary Robert F. Kennedy Jr. to produce documents around cuts to HIV/AIDS funding under the Trump administration.